Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 865783-99-9
2. On-014185
3. Briciclib (on-013105)
4. On 014185
5. Briciclib (on-014185)
6. 865783-99-9 (free Acid)
7. Wg93x96336
8. (e)-2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)phenyl Dihydrogen Phosphate
9. Phenol, 2-methoxy-5-((((1e)-2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl)methyl)-, 1-(dihydrogen Phosphate)
10. Phenol, 2-methoxy-5-[[[(1e)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]-, 1-(dihydrogen Phosphate)
11. Briciclib [usan:inn]
12. On-013105
13. Unii-wg93x96336
14. Briciclib [usan]
15. Briciclib [inn]
16. Briciclib (usan/inn)
17. Briciclib [who-dd]
18. Briciclib; On 014185
19. Schembl1634579
20. Schembl1634581
21. Chembl1206245
22. [2-methoxy-5-[[(e)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]phenyl] Dihydrogen Phosphate
23. Amy42169
24. Bcp17292
25. Ex-a2492
26. Mfcd22665751
27. S6533
28. Zinc28965775
29. Cs-5589
30. Db12004
31. Ac-36098
32. Hy-16366
33. Briciclib(on 013105,on 014185)
34. D10614
35. Q27292622
36. (2-methoxy-5-{[(e)-2-(2,4,6-trimethoxyphenyl)ethenesulfonyl]methyl}phenoxy)phosphonic Acid
37. (e)-5-((2,4,6-trimethoxystyrylsulfonyl)methyl)-2-methoxyphenyl Dihydrogen Phosphate
38. On013105; On-013105; On 013105;on-014185;on 014185;on014185
39. (e)-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)-2-methoxyphenyl Dihydrogen Phosphate
40. 2-methoxy-5-(((2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl)methyl)phenyl Dihydrogen Phosphate
41. Phenol, 2-methoxy-5-[[[(1e)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl] Methyl]-, 1-(dihydrogen Phosphate)
42. Phenol,2-methoxy-5-[[[(1e)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]-,1-(dihydrogen Phosphate)
| Molecular Weight | 474.4 g/mol |
|---|---|
| Molecular Formula | C19H23O10PS |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 10 |
| Exact Mass | 474.07495510 g/mol |
| Monoisotopic Mass | 474.07495510 g/mol |
| Topological Polar Surface Area | 146 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 717 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
21
PharmaCompass offers a list of ON 013105 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right ON 013105 manufacturer or ON 013105 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred ON 013105 manufacturer or ON 013105 supplier.
PharmaCompass also assists you with knowing the ON 013105 API Price utilized in the formulation of products. ON 013105 API Price is not always fixed or binding as the ON 013105 Price is obtained through a variety of data sources. The ON 013105 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ON 013105 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ON 013105, including repackagers and relabelers. The FDA regulates ON 013105 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ON 013105 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ON 013105 supplier is an individual or a company that provides ON 013105 active pharmaceutical ingredient (API) or ON 013105 finished formulations upon request. The ON 013105 suppliers may include ON 013105 API manufacturers, exporters, distributors and traders.
ON 013105 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ON 013105 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ON 013105 GMP manufacturer or ON 013105 GMP API supplier for your needs.
A ON 013105 CoA (Certificate of Analysis) is a formal document that attests to ON 013105's compliance with ON 013105 specifications and serves as a tool for batch-level quality control.
ON 013105 CoA mostly includes findings from lab analyses of a specific batch. For each ON 013105 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ON 013105 may be tested according to a variety of international standards, such as European Pharmacopoeia (ON 013105 EP), ON 013105 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ON 013105 USP).
